[Clinical effect of low-dose Ara-c and its mechanism of antileukemic action].
D001853:Bone Marrow / Q000473:pathology; D003561:Cytarabine / Q000008:administration & dosage*; D004334:Drug Administration Schedule; D006801:Humans; D009190:Myelodysplastic Syndromes / Q000188:drug therapy* / Q000473:pathology; D012074:Remission Induction
D003561:Cytarabine